• hlooho_banner_01

Cagrilintide

Tlhaloso e Khutšoanyane:

Cagrilintide ke amylin receptor agonist ea maiketsetso, ea nako e telele, e etselitsoeng ho phekola botenya le mathata a amanang le boima ba 'mele. Ka ho etsisa hormone ea tlhaho ea amylin, e thusa ho laola takatso ea lijo, ho lieha ho tsoa ka mpeng, le ho matlafatsa ho khora. API ea rona ea boleng bo phahameng ea Cagrilintide e hlahisoa ka lik'hemik'hale tsa lik'hemik'hale 'me e kopana le litekanyetso tsa litekanyetso tsa meriana, e leng se etsang hore e loketse ho sebelisoa mefuteng e tsoetseng pele ea ho laola boima ba' mele.


Lintlha tsa Sehlahisoa

Li-tag tsa Sehlahisoa

Cagrilintide API

Cagrilintideke ntho e sebetsang nako e telele, e entsoeng ka lik'hemik'haleamylin receptor agonist, e ntlafalitsoeng e le pheko e ncha bakeng sabotenya le mathata a amanang le boima ba 'mele. E etselitsoe ho etsisa liphello tsaamylin ea mothoHormone e kopantsoeng le insulin ke lisele tsa pancreatic β, tse bapalang karolo ea bohlokoa ho laola ho jeoa ha lijo, ho tsoa ka mpeng le ho khora.

Cagrilintide e ntse e ntlafatsoa joalo kakalafo e nang le ente hang ka beke, e fanang ka tharollo e tšepisang haholo bakeng sataolo ya boima bo sa foleng, haholo ha e sebelisoa kaHo kopana le GLP-1 receptor agonistsjoalo kaSemaglutide.


Mokhoa oa Ts'ebetso

Cagrilintide e fana ka litlamorao tsa eona tsa kalafo ka ho tlama le ho kenya tšebetsongli-receptor tsa amylin, e lebisang ho:

  • Khatello ea takatso ea lijo

  • Ho tsoa ka maleng ho lieha, e lelefatsang maikutlo a ho tlala

  • Ho fokotseha ha khalori le ho eketseha ha satiety

Taolo ena ea multimodal ea ho ja lijo e etsa hore e be mokhethoa ea loketseng ho laolabotenya le likotsi tse amanang le cardiometabolic.


Lipatlisiso le Boitsebiso ba Clinical

Cagrilintide e bontšitse liphetho tse tšepisang litekong tse 'maloa tsa bongaka, ho kenyelletsaLithuto tsa Phase 2 tse entsoeng ke Novo Nordisk:

  • Ha e sebelisoafeela, Cagrilintide e lebisa hotahlehelo ea boima ba 'mele e itšetlehileng ka tekanyo, ka ho fihlelaPhokotso ea boima ba 'mele ka 10.8%.ho feta libeke tse 26 ho batho ba batenya.

  • Nenge kopantsoe le Semaglutide, phello ea ho theola boima ba 'mele e matlafatsoa haholo-ho finyellaphokotso e kgolo ya boima ba mmele hofeta moemeli a le mong.

  • E bontšitsemamello e ntleleboemo bo tsitsitseng ba polokeho, 'me boholo ba liketsahalo tse bohloko ke matšoao a bobebe a mala.

Mokhoa ona oa ho kopanya ke karolo ea bohlokoa eamoloko o latelang oa lithethefatsi tse khahlanong le botenya, e shebileng litsela tse ngata tsa ho khora (amylin + GLP-1).


Boleng ba API le Tlhahiso

Tsa ronaCagrilintide API:

  • E hlahiswa ka e tsoetseng pelesolid-phase peptide synthesis (SPPS)ka bohloeki bo phahameng le botsitso ba lik'hemik'hale

  • E etselitsoentshetsopele ya sebopeho sa ente

  • Kopana le machabalitekanyetso tsa meriana (ICH, GMP, FDA)

  • E fumaneha hoteko ea tlhahiso ea khoebo, e loketseng ts'ebeliso ea bongaka le ea indasteri


Matla a Phekolo

Cagrilintide e emela amochine o mochataolong ea boima ba 'mele ho feta monotherapy ea GLP-1. Profaele ea eona ea ketso e tlatselletsang e etsa hore e tšoanelehe bakeng sa:

  • Bakuli ba botenya le ba batenya haholo(ka lefu la tsoekere kapa ntle le lona)

  • Phekolo ea motsoakobakeng sa ho fokotsa boima ba 'mele

  • Tsoelo pele ka moso kametabolic syndrome le prediabetes


  • E fetileng:
  • E 'ngoe:

  • Ngola molaetsa wa hao mona mme o re romele wona